Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
187.27
+13.96 (8.05%)
Feb 3, 2026, 4:00 PM EST - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $7.03 billion as of February 4, 2026. Its market cap has increased by 304.75% in one year.
Market Cap
7.03B
Enterprise Value
6.75B
1-Year Change
304.75%
Ranking
Category
Stock Price
$187.27
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $7.03B, an increase of 4,759.43%. That is a compound annual growth rate of 180.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 7.03B | 17.07% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytokinetics | 7.73B |
| Vaxcyte | 7.01B |
| Rhythm Pharmaceuticals | 6.84B |
| Caris Life Sciences | 6.53B |
| Mirum Pharmaceuticals | 6.18B |
| ImmunityBio | 6.16B |
| Structure Therapeutics | 6.12B |
| PTC Therapeutics | 6.06B |